Adaptive Biotechnologies ... (ADPT)
8.13
-0.13 (-1.57%)
At close: Mar 03, 2025, 3:59 PM
8.10
-0.31%
After-hours: Mar 03, 2025, 04:55 PM EST
Adaptive Biotechnologies Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 65.06M | 90.03M | 139.06M | 123.44M | 96.58M | 55.03M | 85.31M |
| Short-Term Investments | 281.34M | 408.17M | 214M | 564.83M | 480.29M | 109.99M | 106.84M |
| Long-Term Investments | n/a | 2.4M | 217.15M | 118.53M | 105.44M | 247K | 8.9M |
| Other Long-Term Assets | 6.52M | 4.46M | 3.01M | 2.74M | 2.92M | 247K | 86K |
| Receivables | 37.97M | 40.06M | 17.41M | 10.05M | 12.68M | 4.81M | 5.58M |
| Inventory | 14.45M | 14.45M | 19.26M | 14.06M | 9.07M | 7.84M | 4.79M |
| Other Current Assets | 11.37M | 9.44M | 13.02M | 14.54M | 25.46M | 3.06M | 2.72M |
| Total Current Assets | 410.19M | 562.15M | 402.75M | 726.91M | 612.69M | 180.72M | 205.25M |
| Property-Plant & Equipment | 120.32M | 164.21M | 172.94M | 139.04M | 60.35M | 19.13M | 13.95M |
| Goodwill & Intangibles | 124.1M | 125.8M | 127.5M | 129.2M | 130.9M | 132.6M | 134.3M |
| Total Long-Term Assets | 250.95M | 294.47M | 520.6M | 389.5M | 299.61M | 151.97M | 157.24M |
| Total Assets | 661.13M | 856.62M | 923.34M | 1.12B | 912.3M | 332.69M | 362.49M |
| Account Payables | 7.72M | 8.08M | 3.31M | 3.24M | 4.45M | 1.79M | 1.96M |
| Deferred Revenue | 48.63M | 64.11M | 80.46M | 73.32M | 60.99M | 12.7M | 14.05M |
| Short-Term Debt | 14.47M | 18.46M | 10.11M | 7.06M | n/a | n/a | n/a |
| Other Current Liabilities | 22.22M | 18.93M | 19.54M | 19.82M | 12.87M | 8.31M | 4.99M |
| Total Current Liabilities | 88.02M | 109.79M | 113.81M | 105.2M | 78.31M | 22.8M | 21M |
| Long-Term Debt | 220.05M | 98.77M | 106.69M | 104.33M | 36.61M | 561.19M | n/a |
| Other Long-Term Liabilities | n/a | 125.36M | n/a | n/a | 7.01M | 6.1M | 566.1M |
| Total Long-Term Liabilities | 264.84M | 282.73M | 205.44M | 267.95M | 262.95M | 568M | 566.1M |
| Total Liabilities | 352.86M | 392.52M | 319.24M | 373.15M | 341.26M | 590.8M | 587.11M |
| Total Debt | 229.43M | 108M | 111.74M | 107.86M | 36.61M | 561.19M | 561.67M |
| Common Stock | 14K | 14K | 14K | 14K | 12K | 1K | 1K |
| Retained Earnings | -1.14B | -919.08M | -718.89M | -511.61M | -365.48M | -295.91M | -249.42M |
| Comprehensive Income | 215K | -4.12M | -1.14M | 893K | 671K | -107K | -166K |
| Shareholders Equity | 308.4M | 464.17M | 603.99M | 743.27M | 571.04M | -258.11M | -224.62M |
| Total Investments | 281.34M | 408.17M | 431.14M | 683.36M | 585.73M | 109.99M | 115.75M |